Antonio Migliarese - 18 May 2021 Form 3 Insider Report for CytoDyn Inc. (CYDY)

Role
Chief Financial Officer
Signature
Arian Colachis, Attorney-in-fact
Issuer symbol
CYDY
Transactions as of
18 May 2021
Net transactions value
$0
Form type
3
Filing time
27 May 2021, 21:22:10 UTC
Next filing
10 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CYDY Non-qualified Stock Option (right to buy) 18 May 2021 Common Stock 50,000 $1.03 Direct F1
holding CYDY Non-qualified Stock Option (right to buy) 18 May 2021 Common Stock 50,000 $1.10 Direct F1
holding CYDY Non-qualified Stock Option (right to buy) 18 May 2021 Common Stock 100,000 $5.57 Direct F1
holding CYDY Non-qualified Stock Option (right to buy) 18 May 2021 Common Stock 50,000 $5.54 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Non-qualified stock option vests in three equal annual installments beginning at date stated.